Cabaletta Bio (Nasdaq: CABA) is a late-stage clinical biotechnology company focused on developing and launching curative targeted cell therapies designed specifically for patients with autoimmune diseases. Cabaletta’s lead product candidate, rese-cel, is an investigational 4-1BB-containing fully human CD19-CAR T cell therapy being advanced across the RESET™ (REstoring SElf-Tolerance) clinical development program spanning multiple therapeutic areas, including rheumatology, neurology, and dermatology. Cabaletta Bio’s headquarters and labs are located in Philadelphia, PA. For more information, visit www.cabalettabio.com and connect with us on LinkedIn.
| Website | http://www.cabalettabio.com |
| Revenue | $28.7 million |
| Employees | 202 (165 on RocketReach) |
| Founded | 2017 |
| Address | 2929 Arch St Suite 600, Philadelphia, Pennsylvania 19104, US |
| Phone | +1 267-759-3100 |
| Technologies |
JavaScript
,
HTML
,
Twitter
+12 more
(view full list)
|
| Industry | Biotechnology Research |
| Keywords | Clinical Stage Biotechnology, Cell Therapy Development, Immunotherapy, Biotechnology, Drug Development, Precision Medicine, Rare Diseases, Oncology, Hematology, Gene Therapy, Clinical Trials, Pharmaceutical, Biopharma, Therapeutics, Medical Research, Drug Discovery, Life Sciences |
| Competitors | Novartis, bluebird bio, Gilead Sciences, Atara Biotherapeutics, CRISPR Therapeutics, Editas Medicine, AstraZeneca, Sangamo Therapeutics, Inc., Bristol Myers Squibb, Amgen +35 more (view full list) |
Looking for a particular Cabaletta Bio employee's phone or email?
Cabaletta Bio Questions
The Cabaletta Bio annual revenue was $28.7 million in 2026.
Gwendolyn Binder is the President, Science and Technology of Cabaletta Bio.
165 people are employed at Cabaletta Bio.
Cabaletta Bio is based in Philadelphia, Pennsylvania.
Top Cabaletta Bio Employees
-
Gwendolyn Binder
President, Science and Technology at Cabaletta Bio
Philadelphia, PA, US25+ -
Steven Nichtberger
Co-founder, Chairman, and CEO at Cabaletta Bio
Villanova, PA, US45+ -
Sarah Yuan
Chief Technology Officer at Cabaletta Bio
Boston, MA, US31 -
Anup Marda
Chief Financial Officer at Cabaletta Bio
West Windsor Township, NJ, US13 -
Arun Das
Chief Business Officer at Cabaletta Bio
Philadelphia, PA, US35 -
Steve Gavel
Chief Commercial Officer at Cabaletta Bio
Philadelphia, PA, US15+ -
Samik Basu
Chief Scientific Officer at Cabaletta Bio
Philadelphia, PA, US35+ -
Amy Markey
Vice President, Quality and Compliance at Cabaletta Bio
Philadelphia, PA, US35 -
Raj Tummala
Senior Vice President - Clinical Development at Cabaletta Bio
Philadelphia, PA, US35+ -
Samantha Labarbera
Vice President and Associate General Counsel at Cabaletta Bio
Philadelphia, PA, US24
Related Companies
